Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib

Clinical trial NCT03314740 · COMPLETED

Trial details

NCT number: NCT03314740
Sponsor: Mario Negri Institute for Pharmacological Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2017-06-12
Primary completion: 2021-04-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.